Parallax Volatility Advisers, L.P. Intra Cellular Therapies, Inc. Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $17,294 - $23,875	-741 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$17.61 - $31.86 $2.08 Million - $3.76 Million	-118,143 Reduced 99.38%	741 $19,000
Q2 2019 Aug 14, 2019	BUY	$10.65 - $14.29 $239,316 - $321,110	22,471 Added 23.31%	118,884 $1.54 Million
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $1.05 Million - $1.36 Million	96,413 New	96,413 $1.17 Million
Q1 2018 May 15, 2018	SELL	$15.16 - $25.49 $153,267 - $257,703	-10,110 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$14.27 - $16.79 $1.26 Million - $1.48 Million	-87,978 Reduced 89.69%	10,110 $146,000
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $1.06 Million - $2.17 Million	98,088	98,088 $1.55 Million

379

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.87B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.